Chemtech Industrial Valves net profit falls 77% to ₹69 lakh in Q1FY27
Chemtech Industrial Valves reported Q1FY27 net profit of ₹69.08 lakh, down 77% YoY, while revenue rose 19% to ₹1,136.31 lakh. Rising input costs drove expenses up 71.5%. The company also confirmed compliance with SEBI regulations regarding the use of proceeds from a preferential issue.

*this image is generated using AI for illustrative purposes only.
Chemtech Industrial Valves Limited reported a net profit of ₹69.08 lakh for the quarter ended June 30, 2026, marking a significant 77% decline from the ₹300.51 lakh recorded in Q1FY25. While revenue from operations expanded by 19% year-on-year to ₹1,136.31 lakh, profitability was compressed by rising input costs and other expenses. The Board of Directors approved the unaudited financial results on August 12, 2026, following a review by the Audit Committee and a limited review report submitted by statutory auditor Raju & Prasad.
The company’s total revenue reached ₹1,237.28 lakh, up from ₹1,105.57 lakh in the prior year period. This growth was supported by an increase in revenue from operations to ₹1,136.31 lakh from ₹956.62 lakh. However, other income contracted sharply to ₹100.97 lakh from ₹148.95 lakh, offsetting some of the operational gains. The divergence between revenue growth and profit contraction highlights margin pressure during the quarter.
Financial Performance
| Particulars | Q1FY27 (₹ Lakh) | Q4FY26 (₹ Lakh) | Q1FY26 (₹ Lakh) | Change (%) |
|---|---|---|---|---|
| Revenue from Operations | 1,136.31 | 1,128.50 | 956.62 | +18.8% |
| Other Income | 100.97 | - | 148.95 | -32.2% |
| Total Revenue | 1,237.28 | 1,128.50 | 1,105.57 | +11.9% |
| Total Expenses | 1,147.85 | - | 669.45 | +71.5% |
| Profit Before Tax | 89.43 | 83.48 | 436.12 | -79.5% |
| Net Profit | 69.08 | 59.70 | 300.51 | -77.0% |
| EPS (Basic) | ₹0.37 | ₹0.33 | ₹1.68 | -78.0% |
Expenses surged 71.5% year-on-year to ₹1,147.85 lakh, primarily driven by a rise in cost of materials consumed to ₹897.37 lakh from ₹376.27 lakh. Employee benefits expense also increased to ₹70.32 lakh from ₹62.04 lakh. Finance costs decreased to ₹2.48 lakh from ₹6.58 lakh, providing some relief. Depreciation and amortisation rose to ₹35.32 lakh from ₹26.05 lakh.
Use of Proceeds Compliance
Under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Chemtech Industrial Valves declared no deviation in the use of proceeds raised through the conversion of warrants into equity shares pursuant to a preferential issue. The funds, amounting to ₹7.50 crore received on March 27, 2026, were utilized for long-term funding for capital expenditure, working capital, and general corporate purposes as stated in the offer document. The aggregate amount raised via this preferential route stands at ₹57.25 crore.
What the Numbers Show
The most critical takeaway from Q1FY27 is the severe margin compression despite top-line growth. While revenue from operations grew nearly 19%, the cost of materials consumed more than doubled, increasing by 138% year-on-year. This disproportionate rise in direct costs suggests either a shift in product mix towards higher-cost items or significant inflation in raw material prices. Consequently, the profit before tax plummeted by 79.5%, indicating that the company’s pricing power did not fully transmit these cost increases to customers. Investors should monitor whether this cost trend persists in subsequent quarters or if it reflects a one-off supply chain disruption.
Historical Stock Returns for Chemtech Industrial
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.46% | +2.90% | -7.04% | +2.69% | -34.62% | +420.15% |
Will Chemtech Industrial Valves implement price hikes or renegotiate supplier contracts to mitigate the 138% surge in material costs in upcoming quarters?
How will the company's management address the sharp 32% decline in other income, and is this trend expected to normalize in Q2FY27?
Given the significant margin compression, what specific operational efficiencies or cost-control measures are planned to restore profitability levels seen in FY25?


































